▶ 調査レポート

世界の炭疽ワクチン産業2020-2026

• 英文タイトル:Global Anthrax Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の炭疽ワクチン産業2020-2026 / Global Anthrax Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3010968資料のイメージです。• レポートコード:D0MA3010968
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、140ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、炭疽ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、炭疽ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(生ワクチン、無細胞PAワクチン)、用途別市場規模(人間用、動物用)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・炭疽ワクチンの種類別市場2015-2026:生ワクチン、無細胞PAワクチン
・炭疽ワクチンの用途別市場2015-2026:人間用、動物用
・炭疽ワクチンの北米市場分析
・炭疽ワクチンのアジア市場分析
・炭疽ワクチンの中南米市場分析
・炭疽ワクチンの中東・アフリカ市場分析
・関連企業情報:Emergent BioSolutions、Merial、Merck、Zoetis、Bayer Sanidad Animal、Colorado Serum、PharmAthene、Tiankang、Biogénesis-Bago、CAVAC、Rosenbusch、Agrovet、Vecol、CVCRI、IVPM、Prondil、CDV、Indian Immunologicals、Botswana Vaccine Institute、Ceva Santé Animale、Intervac、JOVAC
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.

Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.

South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.

South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
In 2019, the global Anthrax Vaccines market size was US$ 586.8 million and is forecast to US$ 985.4 million in 2026, growing at a CAGR of 7.6% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anthrax Vaccines.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anthrax Vaccines market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anthrax Vaccines market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anthrax Vaccines market. Readers of the report can become informed about current and future trends of the global Anthrax Vaccines market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anthrax Vaccines markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anthrax Vaccines market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anthrax Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anthrax Vaccines market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anthrax Vaccines market is segmented into
Live Vaccines
Cell free PA Vaccines

Market Segment by Application, the Anthrax Vaccines market is segmented into
Human Use
Animal Use

This report includes the following manufacturers; we can also add the other companies as you want.
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

The study objectives are:
To analyze and research the global Anthrax Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anthrax Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anthrax Vaccines are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anthrax Vaccines Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anthrax Vaccines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Live Vaccines
1.3.3 Cell free PA Vaccines
1.4 Market Segment by Application
1.4.1 Global Anthrax Vaccines Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Human Use
1.4.3 Animal Use
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anthrax Vaccines Revenue (2015-2026)
2.1.1 Global Anthrax Vaccines Revenue (2015-2026)
2.1.2 Global Anthrax Vaccines Sales (2015-2026)
2.2 Anthrax Vaccines Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anthrax Vaccines Sales by Regions (2015-2020)
2.2.2 Global Anthrax Vaccines Revenue by Regions (2015-2020)
2.3 Global Top Anthrax Vaccines Regions (Countries) Ranking by Market Size
2.4 Anthrax Vaccines Industry Trends
2.4.1 Anthrax Vaccines Market Top Trends
2.4.2 Market Drivers
2.4.3 Anthrax Vaccines Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anthrax Vaccines Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anthrax Vaccines Manufacturers by Sales (2015-2020)
3.1.1 Global Anthrax Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anthrax Vaccines Sales in 2019
3.2 Global Top Manufacturers Anthrax Vaccines by Revenue
3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Anthrax Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anthrax Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2019)
3.4 Global Anthrax Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anthrax Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anthrax Vaccines Market
3.7 Key Manufacturers Anthrax Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anthrax Vaccines Historic Market Review by Type (2015-2020)
4.1.2 Global Anthrax Vaccines Sales Market Share by Type (2015-2020)
4.1.3 Global Anthrax Vaccines Revenue Market Share by Type (2015-2020)
4.1.4 Anthrax Vaccines Price by Type (2015-2020)
4.1 Global Anthrax Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anthrax Vaccines Sales Forecast by Type (2021-2026)
4.2.3 Global Anthrax Vaccines Revenue Forecast by Type (2021-2026)
4.2.4 Anthrax Vaccines Price Forecast by Type (2021-2026)

5 Global Anthrax Vaccines Market Size by Application
5.1 Global Anthrax Vaccines Historic Market Review by Application (2015-2020)
5.1.2 Global Anthrax Vaccines Sales Market Share by Application (2015-2020)
5.1.3 Global Anthrax Vaccines Revenue Market Share by Application (2015-2020)
5.1.4 Anthrax Vaccines Price by Application (2015-2020)
5.2 Global Anthrax Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anthrax Vaccines Sales Forecast by Application (2021-2026)
5.2.3 Global Anthrax Vaccines Revenue Forecast by Application (2021-2026)
5.2.4 Anthrax Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anthrax Vaccines Breakdown Data by Company
6.2 North America Anthrax Vaccines Breakdown Data by Type
6.3 North America Anthrax Vaccines Breakdown Data by Application
6.4 North America Anthrax Vaccines Breakdown Data by Countries
6.4.1 North America Anthrax Vaccines Sales by Countries
6.4.2 North America Anthrax Vaccines Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anthrax Vaccines Breakdown Data by Company
7.2 Europe Anthrax Vaccines Breakdown Data by Type
7.3 Europe Anthrax Vaccines Breakdown Data by Application
7.4 Europe Anthrax Vaccines Breakdown Data by Countries
7.4.1 Europe Anthrax Vaccines Sales by Countries
7.4.2 Europe Anthrax Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines Breakdown Data by Company
8.2 Asia Pacific Anthrax Vaccines Breakdown Data by Type
8.3 Asia Pacific Anthrax Vaccines Breakdown Data by Application
8.4 Asia Pacific Anthrax Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Anthrax Vaccines Sales by Regions
8.4.2 Asia Pacific Anthrax Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anthrax Vaccines Breakdown Data by Company
9.2 Latin America Anthrax Vaccines Breakdown Data by Type
9.3 Latin America Anthrax Vaccines Breakdown Data by Application
9.4 Latin America Anthrax Vaccines Breakdown Data by Countries
9.4.1 Latin America Anthrax Vaccines Sales by Countries
9.4.2 Latin America Anthrax Vaccines Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anthrax Vaccines Breakdown Data by Type
10.2 Middle East and Africa Anthrax Vaccines Breakdown Data by Application
10.3 Middle East and Africa Anthrax Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Anthrax Vaccines Sales by Countries
10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Corporation Information
11.1.2 Emergent BioSolutions Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Emergent BioSolutions Anthrax Vaccines Products and Services
11.1.5 Emergent BioSolutions SWOT Analysis
11.1.6 Emergent BioSolutions Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Merial Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Merial Anthrax Vaccines Products and Services
11.2.5 Merial SWOT Analysis
11.2.6 Merial Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Merck Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Merck Anthrax Vaccines Products and Services
11.3.5 Merck SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Zoetis Anthrax Vaccines Products and Services
11.4.5 Zoetis SWOT Analysis
11.4.6 Zoetis Recent Developments
11.5 Bayer Sanidad Animal
11.5.1 Bayer Sanidad Animal Corporation Information
11.5.2 Bayer Sanidad Animal Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Bayer Sanidad Animal Anthrax Vaccines Products and Services
11.5.5 Bayer Sanidad Animal SWOT Analysis
11.5.6 Bayer Sanidad Animal Recent Developments
11.6 Colorado Serum
11.6.1 Colorado Serum Corporation Information
11.6.2 Colorado Serum Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Colorado Serum Anthrax Vaccines Products and Services
11.6.5 Colorado Serum SWOT Analysis
11.6.6 Colorado Serum Recent Developments
11.7 PharmAthene
11.7.1 PharmAthene Corporation Information
11.7.2 PharmAthene Business Overview and Total Revenue (2019 VS 2018)
11.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 PharmAthene Anthrax Vaccines Products and Services
11.7.5 PharmAthene SWOT Analysis
11.7.6 PharmAthene Recent Developments
11.8 Tiankang
11.8.1 Tiankang Corporation Information
11.8.2 Tiankang Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Tiankang Anthrax Vaccines Products and Services
11.8.5 Tiankang SWOT Analysis
11.8.6 Tiankang Recent Developments
11.9 Biogénesis-Bago
11.9.1 Biogénesis-Bago Corporation Information
11.9.2 Biogénesis-Bago Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Biogénesis-Bago Anthrax Vaccines Products and Services
11.9.5 Biogénesis-Bago SWOT Analysis
11.9.6 Biogénesis-Bago Recent Developments
11.10 CAVAC
11.10.1 CAVAC Corporation Information
11.10.2 CAVAC Business Overview and Total Revenue (2019 VS 2018)
11.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 CAVAC Anthrax Vaccines Products and Services
11.10.5 CAVAC SWOT Analysis
11.10.6 CAVAC Recent Developments
11.11 Rosenbusch
11.11.1 Rosenbusch Corporation Information
11.11.2 Rosenbusch Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Rosenbusch Anthrax Vaccines Products and Services
11.11.5 Rosenbusch SWOT Analysis
11.11.6 Rosenbusch Recent Developments
11.12 Agrovet
11.12.1 Agrovet Corporation Information
11.12.2 Agrovet Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Agrovet Anthrax Vaccines Products and Services
11.12.5 Agrovet SWOT Analysis
11.12.6 Agrovet Recent Developments
11.13 Vecol
11.13.1 Vecol Corporation Information
11.13.2 Vecol Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Vecol Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Vecol Anthrax Vaccines Products and Services
11.13.5 Vecol SWOT Analysis
11.13.6 Vecol Recent Developments
11.14 CVCRI
11.14.1 CVCRI Corporation Information
11.14.2 CVCRI Business Overview and Total Revenue (2019 VS 2018)
11.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 CVCRI Anthrax Vaccines Products and Services
11.14.5 CVCRI SWOT Analysis
11.14.6 CVCRI Recent Developments
11.15 IVPM
11.15.1 IVPM Corporation Information
11.15.2 IVPM Business Overview and Total Revenue (2019 VS 2018)
11.15.3 IVPM Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 IVPM Anthrax Vaccines Products and Services
11.15.5 IVPM SWOT Analysis
11.15.6 IVPM Recent Developments
11.16 Prondil
11.16.1 Prondil Corporation Information
11.16.2 Prondil Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Prondil Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Prondil Anthrax Vaccines Products and Services
11.16.5 Prondil SWOT Analysis
11.16.6 Prondil Recent Developments
11.17 CDV
11.17.1 CDV Corporation Information
11.17.2 CDV Business Overview and Total Revenue (2019 VS 2018)
11.17.3 CDV Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 CDV Anthrax Vaccines Products and Services
11.17.5 CDV SWOT Analysis
11.17.6 CDV Recent Developments
11.18 Indian Immunologicals
11.18.1 Indian Immunologicals Corporation Information
11.18.2 Indian Immunologicals Business Overview and Total Revenue (2019 VS 2018)
11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.18.4 Indian Immunologicals Anthrax Vaccines Products and Services
11.18.5 Indian Immunologicals SWOT Analysis
11.18.6 Indian Immunologicals Recent Developments
11.19 Botswana Vaccine Institute
11.19.1 Botswana Vaccine Institute Corporation Information
11.19.2 Botswana Vaccine Institute Business Overview and Total Revenue (2019 VS 2018)
11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.19.4 Botswana Vaccine Institute Anthrax Vaccines Products and Services
11.19.5 Botswana Vaccine Institute SWOT Analysis
11.19.6 Botswana Vaccine Institute Recent Developments
11.20 Ceva Santé Animale
11.20.1 Ceva Santé Animale Corporation Information
11.20.2 Ceva Santé Animale Business Overview and Total Revenue (2019 VS 2018)
11.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.20.4 Ceva Santé Animale Anthrax Vaccines Products and Services
11.20.5 Ceva Santé Animale SWOT Analysis
11.20.6 Ceva Santé Animale Recent Developments
11.21 Intervac
11.21.1 Intervac Corporation Information
11.21.2 Intervac Business Overview and Total Revenue (2019 VS 2018)
11.21.3 Intervac Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.21.4 Intervac Anthrax Vaccines Products and Services
11.21.5 Intervac SWOT Analysis
11.21.6 Intervac Recent Developments
11.22 JOVAC
11.22.1 JOVAC Corporation Information
11.22.2 JOVAC Business Overview and Total Revenue (2019 VS 2018)
11.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.22.4 JOVAC Anthrax Vaccines Products and Services
11.22.5 JOVAC SWOT Analysis
11.22.6 JOVAC Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anthrax Vaccines Sales Channels
12.2.2 Anthrax Vaccines Distributors
12.3 Anthrax Vaccines Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anthrax Vaccines Sales Forecast (2021-2026)
13.1.1 Global Anthrax Vaccines Sales Forecast by Regions (2021-2026)
13.1.2 Global Anthrax Vaccines Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anthrax Vaccines Sales Forecast (2021-2026)
13.2.2 North America Anthrax Vaccines Revenue Forecast (2021-2026)
13.2.3 North America Anthrax Vaccines Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anthrax Vaccines Sales Forecast (2021-2026)
13.3.2 Europe Anthrax Vaccines Revenue Forecast (2021-2026)
13.3.3 Europe Anthrax Vaccines Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anthrax Vaccines Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anthrax Vaccines Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anthrax Vaccines Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anthrax Vaccines Sales Forecast (2021-2026)
13.5.2 Latin America Anthrax Vaccines Revenue Forecast (2021-2026)
13.5.3 Latin America Anthrax Vaccines Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anthrax Vaccines Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anthrax Vaccines Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anthrax Vaccines Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anthrax Vaccines Key Market Segments
Table 2. Ranking of Global Top Anthrax Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anthrax Vaccines Market Size Growth Rate by Type 2021-2026 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Live Vaccines
Table 5. Major Manufacturers of Cell free PA Vaccines
Table 6. Global Anthrax Vaccines Market Share by Application 2019-2025 (M Doses)
Table 7. Global Anthrax Vaccines Market Size by Regions 2015-2020 (M Doses) & (Million US$)
Table 8. Global Anthrax Vaccines Sales by Regions 2015-2020 (M Doses)
Table 9. Global Anthrax Vaccines Sales Market Share by Regions 2015-2020
Table 10. Global Anthrax Vaccines Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Anthrax Vaccines Revenue Market Share by Regions 2015-2020
Table 12. Top Anthrax Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Anthrax Vaccines Key Drivers: Impact Analysis (2021-2026)
Table 15. Anthrax Vaccines Key Challenges
Table 16. Main Points Interviewed from Key Anthrax Vaccines Players: Views for Future
Table 17. Global Anthrax Vaccines Sales by Manufacturers (2015-2020) (M Doses)
Table 18. Global Anthrax Vaccines Sales Share by Manufacturers (2015-2020)
Table 19. Anthrax Vaccines Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Anthrax Vaccines Revenue Share by Manufacturers (2015-2020)
Table 21. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2019)
Table 23. Key Manufacturers Anthrax Vaccines Average Selling Price (ASP) (2015-2020) (USD/K Doses)
Table 24. Key Manufacturers Anthrax Vaccines Plants/Factories Distribution
Table 25. Key Manufacturers Anthrax Vaccines Area Served
Table 26. Date of Key Manufacturers Enter into Anthrax Vaccines Market
Table 27. Key Manufacturers Anthrax Vaccines Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Live Vaccines Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 30. Global Cell free PA Vaccines Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 31. Global Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 32. Global Anthrax Vaccines Sales Share by Type (2015-2020)
Table 33. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Anthrax Vaccines Price (M Doses) by Type (2015-2020)
Table 35. Global Anthrax Vaccines Sales (M Doses) by Type (2021-2026)
Table 36. Global Anthrax Vaccines Sales Share by Type (2021-2026)
Table 37. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Anthrax Vaccines Revenue Share by Type (2021-2026)
Table 39. Global Anthrax Vaccines Price (M Doses) by Type (2021-2026)
Table 40. Global Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 41. Global Anthrax Vaccines Sales Share by Application (2015-2020)
Table 42. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Anthrax Vaccines Price by Application 2015-2020 (USD/K Doses)
Table 44. Global Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 45. Global Anthrax Vaccines Sales Share by Application (2015-2020)
Table 46. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Anthrax Vaccines Revenue Share by Application (2021-2026)
Table 48. Global Anthrax Vaccines Price (M Doses) by Application (2021-2026)
Table 49. North America Anthrax Vaccines Sales by Company (2015-2020) (M Doses)
Table 50. North America Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 51. North America Anthrax Vaccines Sales by Type (2015-2020) (M Doses)
Table 52. North America Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 53. North America Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 54. North America Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 55. North America Anthrax Vaccines Sales by Countries (2015-2020) (M Doses)
Table 56. North America Anthrax Vaccines Sales Market Share by Countries (2015-2020)
Table 57. North America Anthrax Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Anthrax Vaccines Revenue Market Share by Countries (2015-2020)
Table 59. Europe Anthrax Vaccines Sales by Company (2015-2020) (M Doses)
Table 60. Europe Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 61. Europe Anthrax Vaccines Sales by Type (2015-2020) (M Doses)
Table 62. Europe Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 63. Europe Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 64. Europe Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 65. Europe Anthrax Vaccines Sales by Countries (2015-2020) (M Doses)
Table 66. Europe Anthrax Vaccines Sales Market Share by Countries (2015-2020)
Table 67. Europe Anthrax Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Anthrax Vaccines Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Anthrax Vaccines Sales by Regions (2015-2020) (M Doses)
Table 70. Asia Pacific Anthrax Vaccines Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Anthrax Vaccines Sales by Type (2015-2020) (M Doses)
Table 72. Asia Pacific Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 74. Asia Pacific Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Anthrax Vaccines Sales by Countries (2015-2020) (M Doses)
Table 76. Asia Pacific Anthrax Vaccines Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Anthrax Vaccines Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Anthrax Vaccines Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Anthrax Vaccines Sales by Company (2015-2020) (M Doses)
Table 80. Latin America Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 81. Latin America Anthrax Vaccines Sales by Type (2015-2020) (M Doses)
Table 82. Latin America Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 83. Latin America Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 84. Latin America Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 85. Latin America Anthrax Vaccines Sales by Countries (2015-2020) (M Doses)
Table 86. Latin America Anthrax Vaccines Sales Market Share by Countries (2015-2020)
Table 87. Latin America Anthrax Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Anthrax Vaccines Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Anthrax Vaccines Sales by Type (2015-2020) (M Doses)
Table 90. Middle East and Africa Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Anthrax Vaccines Sales by Application (2015-2020) (M Doses)
Table 92. Middle East and Africa Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Anthrax Vaccines Sales by Countries (2015-2020) (M Doses)
Table 94. Middle East and Africa Anthrax Vaccines Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Anthrax Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries (2015-2020)
Table 97. Emergent BioSolutions Company Details
Table 98. Emergent BioSolutions Description and Business Overview
Table 99. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 100. Emergent BioSolutions Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 101. Emergent BioSolutions Anthrax Vaccines Sales Market Share in Global Market
Table 102. Emergent BioSolutions Recent Development
Table 103. Merial Company Details
Table 104. Merial Description and Business Overview
Table 105. Merial Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 106. Merial Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 107. Merial Anthrax Vaccines Sales Market Share in Global Market
Table 108. Merial Recent Development
Table 109. Merck Company Details
Table 110. Merck Description and Business Overview
Table 111. Merck Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 112. Merck Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 113. Merck Anthrax Vaccines Sales Market Share in Global Market
Table 114. Merck Recent Development
Table 115. Zoetis Company Details
Table 116. Zoetis Description and Business Overview
Table 117. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 118. Zoetis Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 119. Zoetis Anthrax Vaccines Sales Market Share in Global Market
Table 120. Zoetis Recent Development
Table 121. Bayer Sanidad Animal Company Details
Table 122. Bayer Sanidad Animal Description and Business Overview
Table 123. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 124. Bayer Sanidad Animal Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 125. Bayer Sanidad Animal Anthrax Vaccines Sales Market Share in Global Market
Table 126. Bayer Sanidad Animal Recent Development
Table 127. Colorado Serum Company Details
Table 128. Colorado Serum Description and Business Overview
Table 129. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 130. Colorado Serum Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 131. Colorado Serum Anthrax Vaccines Sales Market Share in Global Market
Table 132. Colorado Serum Recent Development
Table 133. PharmAthene Company Details
Table 134. PharmAthene Description and Business Overview
Table 135. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 136. PharmAthene Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 137. PharmAthene Anthrax Vaccines Sales Market Share in Global Market
Table 138. PharmAthene Recent Development
Table 139. Tiankang Company Details
Table 140. Tiankang Description and Business Overview
Table 141. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 142. Tiankang Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 143. Tiankang Anthrax Vaccines Sales Market Share in Global Market
Table 144. Tiankang Recent Development
Table 145. Biogénesis-Bago Company Details
Table 146. Biogénesis-Bago Description and Business Overview
Table 147. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. Biogénesis-Bago Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 149. Biogénesis-Bago Anthrax Vaccines Sales Market Share in Global Market
Table 150. Biogénesis-Bago Recent Development
Table 151. CAVAC Company Details
Table 152. CAVAC Description and Business Overview
Table 153. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 154. CAVAC Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 155. CAVAC Anthrax Vaccines Sales Market Share in Global Market
Table 156. CAVAC Recent Development
Table 157. Rosenbusch Company Details
Table 158. Rosenbusch Description and Business Overview
Table 159. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 160. Rosenbusch Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 161. Rosenbusch Anthrax Vaccines Sales Market Share in Global Market
Table 162. Rosenbusch Recent Development
Table 163. Agrovet Company Details
Table 164. Agrovet Description and Business Overview
Table 165. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 166. Agrovet Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 167. Agrovet Anthrax Vaccines Sales Market Share in Global Market
Table 168. Agrovet Recent Development
Table 169. Vecol Company Details
Table 170. Vecol Description and Business Overview
Table 171. Vecol Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 172. Vecol Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 173. Vecol Anthrax Vaccines Sales Market Share in Global Market
Table 174. Vecol Recent Development
Table 175. CVCRI Company Details
Table 176. CVCRI Description and Business Overview
Table 177. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 178. CVCRI Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 179. CVCRI Anthrax Vaccines Sales Market Share in Global Market
Table 180. CVCRI Recent Development
Table 181. IVPM Company Details
Table 182. IVPM Description and Business Overview
Table 183. IVPM Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 184. IVPM Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 185. IVPM Anthrax Vaccines Sales Market Share in Global Market
Table 186. IVPM Recent Development
Table 187. Prondil Company Details
Table 188. Prondil Description and Business Overview
Table 189. Prondil Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 190. Prondil Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 191. Prondil Anthrax Vaccines Sales Market Share in Global Market
Table 192. Prondil Recent Development
Table 193. CDV Company Details
Table 194. CDV Description and Business Overview
Table 195. CDV Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 196. CDV Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 197. CDV Anthrax Vaccines Sales Market Share in Global Market
Table 198. CDV Recent Development
Table 199. Indian Immunologicals Company Details
Table 200. Indian Immunologicals Description and Business Overview
Table 201. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 202. Indian Immunologicals Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 203. Indian Immunologicals Anthrax Vaccines Sales Market Share in Global Market
Table 204. Indian Immunologicals Recent Development
Table 205. Botswana Vaccine Institute Company Details
Table 206. Botswana Vaccine Institute Description and Business Overview
Table 207. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 208. Botswana Vaccine Institute Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 209. Botswana Vaccine Institute Anthrax Vaccines Sales Market Share in Global Market
Table 210. Botswana Vaccine Institute Recent Development
Table 211. Ceva Santé Animale Company Details
Table 212. Ceva Santé Animale Description and Business Overview
Table 213. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 214. Ceva Santé Animale Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 215. Ceva Santé Animale Anthrax Vaccines Sales Market Share in Global Market
Table 216. Ceva Santé Animale Recent Development
Table 217. Intervac Company Details
Table 218. Intervac Description and Business Overview
Table 219. Intervac Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 220. Intervac Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 221. Intervac Anthrax Vaccines Sales Market Share in Global Market
Table 222. Intervac Recent Development
Table 223. JOVAC Company Details
Table 224. JOVAC Description and Business Overview
Table 225. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 226. JOVAC Anthrax Vaccines Sales Growth Rate (2015-2020)
Table 227. JOVAC Anthrax Vaccines Sales Market Share in Global Market
Table 228. JOVAC Recent Development
Table 229. Anthrax Vaccines Distributors List
Table 230. Anthrax Vaccines Customers List
Table 231. Global Anthrax Vaccines Sales Forecast 2021-2026 (M Doses) & (Million US$)
Table 232. Global Anthrax Vaccines Sales Forecast by Type 2021-2026 (M Doses)
Table 233. Global Anthrax Vaccines Sales Forecast by Application 2021-2026 (M Doses)
Table 234. Global Anthrax Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 235. Global Anthrax Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 236. North America Anthrax Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 237. North America Anthrax Vaccines Revenue Forecast by Countries 2021-2026
Table 238. Europe Anthrax Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 239. Europe Anthrax Vaccines Revenue Market Share Forecast by Countries 2021-2026
Table 240. Asia Pacific Anthrax Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 241. Asia Pacific Anthrax Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 242. Latin America Anthrax Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 243. Latin America Anthrax Vaccines Revenue Forecast by Countries 2021-2026 (Million US$)
Table 244. Middle East and Africa Anthrax Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 245. Middle East and Africa Anthrax Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 246. Research Programs/Design for This Report
Table 247. Key Data Information from Secondary Sources
Table 248. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Sales Market Shar by Type 2015-2026
Figure 3. Live Vaccines Figures
Figure 4. Cell free PA Vaccines Figures
Figure 5. Global Anthrax Vaccines Sales Market Share by Application in 2019 & 2026
Figure 6. Human Use Use Case
Figure 7. Animal Use Use Case
Figure 8. Anthrax Vaccines Report Years Considered
Figure 9. Global Anthrax Vaccines Market Size 2015-2026 (Million US$)
Figure 10. Global Anthrax Vaccines Sales 2015-2020 (M Doses)
Figure 11. Global Anthrax Vaccines Market Size Market Share by Regions 2015-2020
Figure 12. Global Anthrax Vaccines Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Anthrax Vaccines Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthrax Vaccines Sales in 2019
Figure 16. Anthrax Vaccines Value Share by Manufacturers in 2019
Figure 17. Anthrax Vaccines Revenue Share by Manufacturers In 2019
Figure 18. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Anthrax Vaccines Revenue Share by Type (2015-2020)
Figure 20. Global Anthrax Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Anthrax Vaccines Market Share by Price Range (2015-2020)
Figure 22. Global Anthrax Vaccines Revenue Share by Application (2015-2020)
Figure 23. Global Anthrax Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Anthrax Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 26. Canada Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 27. Europe Anthrax Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 29. France Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 30. U.K. Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 31. Italy Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 32. Russia Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 33. Asia Pacific Anthrax Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Japan Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 36. South Korea Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 37. India Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 38. Australia Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 39. Taiwan Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Indonesia Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 41. Thailand Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 42. Malaysia Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Philippines Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 44. Vietnam Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 45. Latin America Anthrax Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 47. Brazil Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 48. Argentina Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Middle East and Africa Anthrax Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Saudi Arabia Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 52. U.A.E Anthrax Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 53. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bayer Sanidad Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. PharmAthene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Tiankang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biogénesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Agrovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Vecol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. CVCRI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. IVPM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Prondil Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. CDV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Botswana Vaccine Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Ceva Santé Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Intervac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. JOVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Anthrax Vaccines Value Chain
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. North America Anthrax Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 79. North America Anthrax Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Europe Anthrax Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 81. Europe Anthrax Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 82. Asia Pacific Anthrax Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 83. Asia Pacific Anthrax Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 84. Latin America Anthrax Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 85. Latin America Anthrax Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 86. Middle East and Africa Anthrax Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 87. Middle East and Africa Anthrax Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed